TATVA CHINTAN PHARMA CHEM
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹8.04 Cr | ₹8.04 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹10.00 Cr | ₹10.00 Cr |
Equity - Issued | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹8.04 Cr | ₹8.04 Cr |
Equity Paid Up | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹8.04 Cr | ₹8.04 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹493 Cr | ₹451 Cr | ₹146 Cr | ₹110 Cr | ₹72 Cr |
Securities Premium | ₹209 Cr | ₹209 Cr | - | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹283 Cr | ₹241 Cr | ₹146 Cr | ₹109 Cr | ₹72 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹1.08 Cr | ₹0.43 Cr | ₹0.28 Cr | ₹0.25 Cr | ₹0.04 Cr |
Reserve excluding Revaluation Reserve | ₹493 Cr | ₹451 Cr | ₹146 Cr | ₹110 Cr | ₹72 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹515 Cr | ₹473 Cr | ₹166 Cr | ₹118 Cr | ₹80 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹4.23 Cr | ₹13 Cr | ₹27 Cr | ₹39 Cr | ₹32 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹12 Cr | ₹25 Cr | ₹24 Cr | ₹39 Cr | ₹31 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-7.80 Cr | ₹-12 Cr | ₹2.64 Cr | - | ₹0.16 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-12 Cr | ₹-8.71 Cr | ₹2.08 Cr | ₹4.46 Cr | ₹3.31 Cr |
Deferred Tax Assets | ₹25 Cr | ₹20 Cr | ₹7.22 Cr | ₹1.35 Cr | ₹0.15 Cr |
Deferred Tax Liability | ₹13 Cr | ₹11 Cr | ₹9.30 Cr | ₹5.80 Cr | ₹3.45 Cr |
Other Long Term Liabilities | - | ₹0.01 Cr | ₹1.43 Cr | ₹0.03 Cr | ₹0.04 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.15 Cr | ₹0.65 Cr | ₹0.55 Cr | ₹0.40 Cr | ₹0.29 Cr |
Total Non-Current Liabilities | ₹-6.98 Cr | ₹5.06 Cr | ₹31 Cr | ₹44 Cr | ₹35 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹32 Cr | ₹45 Cr | ₹47 Cr | ₹32 Cr | ₹22 Cr |
Sundry Creditors | ₹32 Cr | ₹45 Cr | ₹47 Cr | ₹32 Cr | ₹22 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹47 Cr | ₹33 Cr | ₹21 Cr | ₹15 Cr | ₹11 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.55 Cr | ₹2.11 Cr | ₹0.65 Cr | ₹0.14 Cr | ₹0.25 Cr |
Interest Accrued But Not Due | ₹0.30 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.26 Cr | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹45 Cr | ₹31 Cr | ₹20 Cr | ₹15 Cr | ₹10 Cr |
Short Term Borrowings | ₹156 Cr | ₹92 Cr | ₹49 Cr | ₹40 Cr | ₹40 Cr |
Secured ST Loans repayable on Demands | ₹156 Cr | ₹92 Cr | ₹49 Cr | ₹40 Cr | ₹40 Cr |
Working Capital Loans- Sec | ₹156 Cr | ₹92 Cr | ₹49 Cr | ₹40 Cr | ₹40 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-156 Cr | ₹-92 Cr | ₹-49 Cr | ₹-40 Cr | ₹-40 Cr |
Short Term Provisions | ₹0.55 Cr | ₹1.20 Cr | ₹11 Cr | ₹0.06 Cr | ₹0.04 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.21 Cr | ₹1.02 Cr | ₹11 Cr | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.33 Cr | ₹0.18 Cr | ₹0.11 Cr | ₹0.06 Cr | ₹0.04 Cr |
Total Current Liabilities | ₹236 Cr | ₹171 Cr | ₹128 Cr | ₹88 Cr | ₹73 Cr |
Total Liabilities | ₹744 Cr | ₹649 Cr | ₹325 Cr | ₹249 Cr | ₹188 Cr |
ASSETS | |||||
Gross Block | ₹232 Cr | ₹186 Cr | ₹139 Cr | ₹122 Cr | ₹73 Cr |
Less: Accumulated Depreciation | ₹36 Cr | ₹27 Cr | ₹18 Cr | ₹11 Cr | ₹6.74 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹196 Cr | ₹160 Cr | ₹120 Cr | ₹111 Cr | ₹67 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹231 Cr | ₹51 Cr | ₹9.81 Cr | ₹4.89 Cr | ₹6.04 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹2.85 Cr | ₹2.09 Cr | ₹0.30 Cr | ₹0.17 Cr | ₹0.38 Cr |
Other Non Current Assets | ₹0.55 Cr | ₹0.51 Cr | - | - | - |
Total Non-Current Assets | ₹430 Cr | ₹214 Cr | ₹131 Cr | ₹116 Cr | ₹73 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹162 Cr | ₹170 Cr | ₹72 Cr | ₹64 Cr | ₹36 Cr |
Raw Materials | ₹30 Cr | ₹46 Cr | ₹21 Cr | ₹20 Cr | ₹8.77 Cr |
Work-in Progress | ₹59 Cr | ₹44 Cr | ₹27 Cr | ₹26 Cr | ₹11 Cr |
Finished Goods | ₹23 Cr | ₹32 Cr | ₹6.60 Cr | ₹7.38 Cr | ₹9.45 Cr |
Packing Materials | ₹1.10 Cr | ₹1.70 Cr | ₹0.73 Cr | ₹0.58 Cr | ₹0.38 Cr |
Stores Ā and Spare | ₹29 Cr | ₹15 Cr | ₹6.86 Cr | ₹3.49 Cr | ₹3.23 Cr |
Other Inventory | ₹21 Cr | ₹31 Cr | ₹10 Cr | ₹5.92 Cr | ₹2.78 Cr |
Sundry Debtors | ₹84 Cr | ₹57 Cr | ₹91 Cr | ₹50 Cr | ₹41 Cr |
Debtors more than Six months | ₹1.58 Cr | - | - | - | - |
Debtors Others | ₹83 Cr | ₹57 Cr | ₹91 Cr | ₹50 Cr | ₹41 Cr |
Cash and Bank | ₹45 Cr | ₹177 Cr | ₹5.34 Cr | ₹11 Cr | ₹16 Cr |
Cash in hand | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.07 Cr |
Balances at Bank | ₹45 Cr | ₹177 Cr | ₹5.26 Cr | ₹11 Cr | ₹16 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹5.13 Cr | ₹5.38 Cr | ₹6.38 Cr | ₹2.85 Cr | ₹3.65 Cr |
Interest accrued on Investments | ₹0.06 Cr | ₹0.58 Cr | ₹0.05 Cr | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | ₹0.05 Cr |
Prepaid Expenses | ₹3.71 Cr | ₹2.12 Cr | ₹1.51 Cr | ₹0.82 Cr | ₹0.44 Cr |
Other current_assets | ₹1.36 Cr | ₹2.67 Cr | ₹4.82 Cr | ₹2.04 Cr | ₹3.17 Cr |
Short Term Loans and Advances | ₹17 Cr | ₹27 Cr | ₹20 Cr | ₹5.89 Cr | ₹18 Cr |
Advances recoverable in cash or in kind | ₹4.50 Cr | ₹12 Cr | ₹1.73 Cr | ₹0.02 Cr | ₹2.42 Cr |
Advance income tax and TDS | ₹5.54 Cr | - | ₹10 Cr | ₹3.10 Cr | ₹5.73 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹6.72 Cr | ₹15 Cr | ₹8.04 Cr | ₹2.77 Cr | ₹9.99 Cr |
Total Current Assets | ₹314 Cr | ₹436 Cr | ₹195 Cr | ₹133 Cr | ₹114 Cr |
Net Current Assets (Including Current Investments) | ₹77 Cr | ₹264 Cr | ₹66 Cr | ₹45 Cr | ₹42 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹744 Cr | ₹649 Cr | ₹325 Cr | ₹249 Cr | ₹188 Cr |
Contingent Liabilities | ₹1.46 Cr | ₹3.34 Cr | ₹0.51 Cr | ₹0.68 Cr | ₹0.43 Cr |
Total Debt | ₹170 Cr | ₹120 Cr | ₹90 Cr | ₹91 Cr | ₹77 Cr |
Book Value | 232.25 | 213.44 | 82.62 | 146.48 | 99.19 |
Adjusted Book Value | 232.25 | 213.44 | 82.62 | 58.59 | 39.68 |
Compare Balance Sheet of peers of TATVA CHINTAN PHARMA CHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TATVA CHINTAN PHARMA CHEM | ₹2,848.7 Cr | -3.2% | -9.5% | -32.7% | Stock Analytics | |
PIDILITE INDUSTRIES | ₹143,804.0 Cr | 4% | 9.7% | 25.7% | Stock Analytics | |
SOLAR INDUSTRIES INDIA | ₹77,156.8 Cr | 7.9% | 35.1% | 139.9% | Stock Analytics | |
SRF | ₹74,909.5 Cr | 6.1% | 8.2% | 8.6% | Stock Analytics | |
GUJARAT FLUOROCHEMICALS | ₹39,553.7 Cr | -0.8% | -13% | 0.9% | Stock Analytics | |
DEEPAK NITRITE | ₹30,963.9 Cr | 1.2% | -7.2% | 20.3% | Stock Analytics |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TATVA CHINTAN PHARMA CHEM | -3.2% |
-9.5% |
-32.7% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses